Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | -40.00% | -40.00% | +15.38% |
2023 | Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. | CI |
2023 | Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+15.38% | 5.54K | |
-42.58% | 2.85B | |
+20.51% | 1.94B | |
-1.13% | 1.68B | |
+27.00% | 1.26B | |
-14.07% | 1.03B | |
-20.60% | 938M | |
+0.88% | 783M | |
-24.73% | 628M | |
+8.73% | 535M |
- Stock Market
- Equities
- HTGMQ Stock
- News HTG Molecular Diagnostics, Inc.
- HC Wainwright Adjusts Price Target on HTG Molecular Diagnostics to $2 From $3, Reiterates Buy Rating